The importance of molecular studies in the diagnosis and monitoring of IgE-mediated cow's milk protein allergy in children: a pilot study

分子研究在儿童IgE介导的牛奶蛋白过敏的诊断和监测中的重要性:一项初步研究

阅读:1

Abstract

INTRODUCTION: Cow's milk protein allergy (CMPA) affects up to 3% of the paediatric population. The most reliable diagnostic tool for CMPA is oral food challenge (OFC), which may carry risks for the patient. AIM: The aim of this study was to assess the usefulness of molecular testing for CMPA in diagnosing and evaluating tolerance acquisition in children with IgE-dependent allergy to this food. MATERIAL AND METHODS: The study included 49 children (average age: 2 years and 8 months) with an IgE-dependent allergy CMPA. Data from medical history was analysed at two time points, including the assessment of allergen-specific IgE (asIgE) against cow's milk extract, α-lactalbumin, β-lactoglobulin, casein, and bovine serum albumin, measured using the fluoroimmunoenzymatic assay (FEIA). Additionally, results from OFC with baked and raw cow's milk were included. RESULTS: For both baked and raw milk allergies, the best marker for clinical reactivity was the asIgE level for casein (≥ 7.01 kU/l; AUC = 0.869 for baked milk and ≥ 5.96 kU/l; AUC = 0.710 for raw milk). The optimal asIgE level, measured by FEIA, to assess the risk of anaphylaxis during the OFC with baked milk was ≥ 7.01 kU/l for casein (AUC = 0.60). The marker for anaphylaxis in the course of OFC with raw milk was asIgE for β-lactoglobulin ≥ 1.71 kU/l (AUC = 0.724). For monitoring CMPA, the most useful markers were asIgE for casein, milk extract, and both α-lactalbumin and β-lactoglobulin. CONLUSIONS: For both baked and raw milk allergies, the best marker for clinical reactivity remains casein. Testing for cow's milk allergens using solely molecular methods is insufficient for diagnosing and monitoring CMPA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。